Orthogonal activation of the reengineered A(3) adenosine receptor (neoceptor) using tailored nucleoside agonists

An alternative approach to overcome the inherent lack of specificity of conventional agonist therapy can be the reengineering of the GPCRs and their agonists. A reengineered receptor (neoceptor) could be selectively activated by a modified agonist, but not by the endogenous agonist. Assisted by rhod...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Gao, Zhan-Guo, Duong, Heng T., Sonin, Tatiana, Kim, Soo-Kyung, Van Rompaey, Philippe, Van Calenbergh, Serge, Mamedova, Liaman, Kim, Hea Ok, Kim, Myong Jung, Kim, Ae Yil, Liang, Bruce T., Jeong, Lak Shin, Jacobson, Kenneth A.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2006
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3471142/
https://ncbi.nlm.nih.gov/pubmed/16640329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/jm050968b
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi